Dr John Michael Dubensky, DO | |
825 Fairfax Ave Ste 610, Norfolk, VA 23507-1914 | |
(757) 446-8960 | |
Not Available |
Full Name | Dr John Michael Dubensky |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 825 Fairfax Ave Ste 610, Norfolk, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376103283 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | OT019138 (Pennsylvania) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | 0116037769 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr John Michael Dubensky, DO 825 Fairfax Ave Ste 610, Norfolk, VA 23507-1914 Ph: (757) 446-8960 | Dr John Michael Dubensky, DO 825 Fairfax Ave Ste 610, Norfolk, VA 23507-1914 Ph: (757) 446-8960 |
News Archive
In a rarely seen case, a 30-year-old woman presented to the doctors at the emergency department with a worsening pain at the centre of her abdomen. The pain was colicky over the last couple of days and on investigations the team of doctors found that it was due to something she had swallowed years earlier. The report of this case was published this week in the journal BMJ reports.
For two decades, doctors have followed an ethically-established agreement about the appropriate use of artificial nutrition and hydration (ANH) for patients who are seriously ill or in a persistent vegetative state.
Appropriately selected anticoagulation therapy can help to reduce the medical costs of patients suffering from atrial fibrillation. A new study from the University of Eastern Finland shows that direct oral anticoagulants can be a more cost-effective alternative than traditional warfarin therapy when the patient's place of residence is taken into consideration.
Hi-Tech Pharmacal Co., Inc. today reported results for the Company's fiscal first quarter ended July 31, 2011.
› Verified 4 days ago